Laryngeal mucosa: Its susceptibility to damage by acid and pepsin

Laryngoscope

Volumn 120, Issue 4, 2010, Pages 777-782

  Bulmer, David M ^a   Ali, Mahmoud S ^a   Brownlee, Iain A ^a   Dettmar, Peter W ^b   Pearson, Jeffrey P ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b Technostics Limited   (United Kingdom)

Author keywords

Acid; Damage; Larynx; Pepsin; Posterior commissure

Indexed keywords

DNA; HYDROCHLORIC ACID; PEPSIN A;

ACIDITY; ALKALINITY; ANATOMICAL VARIATION; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA DETERMINATION; GLOTTIS; HISTOLOGY; LARYNGOPHARYNGEAL REFLUX; LARYNX INJURY; LARYNX MUCOSA; NONHUMAN; OPTICAL DENSITY; PH MEASUREMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SWINE; TISSUE SECTION; VOCAL CORD;

ANIMALS; DISEASE MODELS, ANIMAL; GASTRIC ACID; HYDROGEN-ION CONCENTRATION; LARYNGEAL MUCOSA; LARYNX; PEPSIN A; PROSPECTIVE STUDIES; REGURGITATION, GASTRIC; SWINE;

EID: 77950791124     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.20665     Document Type: Article

References (16)

1. Koufman JA, Aviv JE, Casiano RR, et al. Laryngopharyngeal reflux: position statement of the Committee on Speech, Voice, and Swallowing Disorders of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngol Head Neck Surg 2002;127:32-35.
2. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991;101(suppl 53):1-78.
3. Oridate N, Takeda H, Yamamoto J, et al. Helicobacter pylori seropositivity predicts outcomes of acid suppression therapy for laryngopharyngeal reflux symptoms. Laryngoscope 2006;116:547-553. (Pubitemid 44318063)
4. Ludemann JP, Manoukian J, Shaw K, Bernard C, Davis M, al-Jubab A. Effects of simulated gastroesophageal reflux on the untraumatised rabbit larynx. J Otolaryngol 1998; 27:127-131. (Pubitemid 28340585)
5. Ali MS. Laryngopharyngeal reflux: diagnosis and treatment of a controversial disease. Curr Opin Allergy Clin Immunol 2008;8:28-33.
6. Johnston N, Bulmer D, Gill GA, et al. Cell biology of laryngeal epithelial defences in health and disease: further studies. Ann Otol Rhinol Laryngol 2003;112:481-491. (Pubitemid 36712702)
7. Johnston N, Dettmar PW, Bishwokarma B, et al. Activity/stability of human pepsin: implications for reflux attributed laryngeal disease. Laryngoscope 2007;117:1036-1039. (Pubitemid 46869842)
8. Johnston N, Knight J, Dettmar PW, et al. Pepsin and carbonic anhydrase isoenzyme III as diagnostic markers for laryngopharyngeal reflux disease. Laryngoscope 2004; 114:2129-2134. (Pubitemid 39602477)
9. Jacyna MR, Ross PE, Bakar MA, Hopwood D, Bouchier IA. Characteristics of cholesterol absorption by human gall bladder: relevance to cholesterolosis. J Clin Pathol 1987; 40:524-529.
10. Hinegarder RT. An improved fluorometric assay for DNA. Anal Biochem 1971;39:197-201.
11. Kiernan JA. Histology and Histochemical Methods. 4th ed. Oxfordshire, UK: Scion Publishing; 2008.
12. Birchall MA, Bailey M, Barker EV, Rothkotter HJ, Otto K, Macchiarini P. Model for experimental revascularized laryngeal allotransplantation. Brit J Surg 2002;89: 1470-1475.
13. Toohill RJ, Kuhn JC. Role of refluxed acid in pathogenesis of laryngeal disorders. Am J Medicine 1997;103: 100S-106S.
14. Belafsky PC, Postma GN, Amin MR, Koufman JA. Symptoms and findings of laryngopharyngeal reflux. Ear Nose Throat J 2002;81:10-13.
15. Johnston N, Wells CW, Blumin JH, Toohill RJ, Merati AL. Receptor mediated uptake of pepsin by laryngeal epithelial cells. Ann Otol Rhinol Laryngol 2007;116: 934-938. (Pubitemid 350308794)
16. Rucci L, Bocciolini C, Romagnoli P, Olofsson J. Risk factors and prognosis of anterior commissure versus posterior commissure T1-T2 glottic cancer. Ann Otol Rhinol Laryngol 2003;112:223-229. (Pubitemid 36297716)